Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
Hodi
F Stephen
FS
Dana-Farber Cancer Institute, Boston, MA 02115, USA. Stephen_Hodi@DFCI.Harvard.Edu
Granter
Scott
S
Antin
Joseph
J
D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008545:Melanoma / Q000150:complications / Q000276:immunology* / Q000628:therapy; D012074:Remission Induction; D020123:Sirolimus / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus